9 Reasons James Comey Might Be in Real Legal Jeopardy <

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone
180
9 Reasons James Comey Might Be in Real Legal Jeopardy
< >

Disgraced former FBI Director James Comey might be in some real legal jeopardy now that Attorney General William Barr has assigned a prosecutor to investigate the Russia Hoax investigators, of whom Comey was the ringleader.

Comey’s emerging sins appear to range from possibly illegal to outright unethical to obviously partisan. In no particular order, here is a handy rundown of all the controversial issues [updated to nine] surrounding Comey that have yet to be settled, properly investigated, or explained.

1.Comey Conducted High-Level Investigations out of FBI Headquarters

It was Comey’s decision to run the investigation of Hillary Clinton’s email server and the counterintelligence probe of the Trump campaign out of his office at FBI headquarters — as opposed to having a field office handle it, which is the normal course of events.

The reasons for this are obvious: you do not want political investigations at this level tainted by the hotbed of partisanship that is Washington, DC.

Kevin R. Brock, a former assistant director of intelligence for the FBI, explains it this way:

Conducting any investigation — as Comey did — out of FBI headquarters, let alone the Director’s Office, is not by the book. It is so outside “the book” that current FBI Director Christopher Wray is implementing policy, according to reliable internal sources, that restores investigations exclusively to the field offices and prohibits headquarters — where the FBI most closely intersects with the flame of political D.C. — from ever conducting investigations again.

Comey is a political appointee. For him to conduct these investigations out of his own office is an outrageous conflict of interest. The ripple effects of this decision are listed below.
2.Comey Grabbed Authority He Did Not Have to Clear Hillary Clinton

To begin with, Hillary Clinton has every right to be furious with Comey for holding his unprincipled news conference back in July 2016 where he announced she would not be charged over the issues surrounding her home-brewed server. But he then went on to lay out a damning case against her recklessness and carelessness with classified material, even though it is highly unethical for anyone in law enforcement to lay out a case against someone who is not going to be charged.

What was truly outrageous, though, was Comey grabbing authority he did not have in announcing Hillary would not be charged. He is the FBI director, not a prosecutor. His job is to investigate and present his findings to a prosecutor, in this case, then-Attorney General Loretta Lynch.

Lynch recused herself from the email case after her “secret” tarmac meeting with Bill Clinton became public, but that still doesn’t give Comey the authority to rewrite the Constitution so that he becomes a member of the judicial branch.

This was so sleazy, so political, so helpful to the Obama administration, at the very least, Comey deserved to be sanctioned.
3. The Phony FISA Warrant Based on the Phony Russia Dossier

The FBI’s FISA warrant, which allowed Comey’s investigation to wiretap a Trump campaign staffer, and by extension, the Trump campaign, was primarily based on the Steele Dossier, which Comey knew was 1) “salacious” and “unverified,” 2) a product of the Clinton campaign and Democrat National Committee, and 3) put together by Christopher Steele, a foreign national and hyper-partisan who we now know was desperate to destroy Trump’s campaign.

John Solomon explains:

The FBI fired Steele on Nov. 1, 2016 — two weeks after securing the warrant — on the grounds that he had unauthorized contacts with the news media.

But the FBI withheld from the American public and Congress, until months later, that Steele had been paid to find his dirt on Trump by a firm doing political opposition research for the Democratic Party and for Democratic presidential candidate Hillary Clinton, and that Steele himself harbored hatred for Trump.

If the FBI knew of his media contacts and the concerns about the reliability of his dossier before seeking the warrant, it would constitute a serious breach of FISA regulations and the trust that the FISA court places in the FBI.

That’s because the FBI has an obligation to certify to the court before it approves FISA warrants that its evidence is verified, and to alert the judges to any flaws in its evidence or information that suggest the target might be innocent.

This abuse of power and dishonesty would be bad enough concerning an average citizen, but because this abuse was targeted at an ongoing presidential campaign, it was an abuse against every citizen in this country — all of us.

4. The Phony Documentation in the FISA Warrant that “Corroborated” the Steele Dossier

To obtain the warrant to spy on the Trump campaign, the FBI needed an outside source to corroborate the phony Steele Dossier, so Comey’s FBI cited a Yahoo News article as independent corroboration, which was a lie. The Yahoo article was premised on the Steele Dossier. The FISA court was not told this.

On this issue, John Solomon nails a point home that Barr’s Russia Hoax investigator, Connecticut U.S. attorney John Durham, needs to get to the bottom of:

If the FBI knew Steele had that media contact before it submitted the article, it likely would be guilty of circular intelligence reporting, a forbidden tactic in which two pieces of evidence are portrayed as independent corroboration when, in fact, they originated from the same source.

These issues are why the FBI email chain, kept from most members of Congress for the past two years, suddenly landed on the declassification list.

This timeline must be confirmed and made public ASAP.

5. Comey Launched a Full Counterintelligence Operation Against the Trump Campaign Based on a Dossier He Knew Was Phony

This is the most damning and under-covered act Comey committed, and I sure as hell hope Durham digs into this because Comey’s over-arching behavior is beyond contempt. Let me see if I can find the words to express just how obscene Comey’s behavior was…

Based on a dossier he knew was a fake document paid for and compiled by anti-Trump partisans, Comey launched an intensive spying campaign against Team Trump as though they were the criminals, as though they were suspected of a crime.

This intense spying campaign, which was obviously meant to entrap people into admitting to treason and to meddle in a presidential election, involved no less than a full-fledged counterintelligence investigation using confidential sources, non-FBI undercover investigators, and wiretaps.

This is not only un-American, as explained below; it is unprecedented…

6. Comey Chose to Spy on Team Trump Rather than Warn Them

Kevin R. Brock lays this out perfectly [emphasis added]:

Targeting U.S. citizens working for a presidential campaign with confidential sources, non-FBI undercover investigators, and Foreign Intelligence Surveillance Act (FISA) electronic surveillance, is not normal. It’s never been done before. There is no “book” for it.

In addition, experienced counterintelligence investigators will tell you that when there is an intersection of Russian intelligence operatives and a U.S. citizen, the normal “book” calls for the FBI to warn the American about Russian intelligence “tricks” and then obtain cooperation, to help learn even more about Russian objectives.

This traditional book was not followed by Comey’s team, nor were those courtesies extended to the Trump campaign. Instead, campaign members were immediately targeted for investigation.

Once again, based on a dossier he knew was phony, Comey treated the Trump campaign like they were the wrongdoers rather than request their cooperation is nabbing the actual wrongdoers, the Russians looking to influence the campaign.

7. Comey Leaked FBI Materials to the Media

After Trump fired him, Comey leaked internal FBI material to the media in the hope that his leak would result in the appointment of a special counsel, which is exactly what happened.

Jonathan Turley explains the many ways in which this could (and should) be a problem for Comey:

Besides being subject to Nondisclosure Agreements, Comey falls under federal laws governing the disclosure of classified and nonclassified information. Assuming that the memos were not classified (though it seems odd that it would not be classified even on the confidential level), there is 18 U.S.C. § 641 which makes it a crime to steal, sell, or convey “any record, voucher, money, or thing of value of the United States or of any department or agency thereof.”

There are also ethical and departmental rules against the use of material to damage a former represented person or individual or firm related to prior representation. The FBI website states:

Dissemination of FBI information is made strictly in accordance with provisions of the Privacy Act; Title 5, United States Code, Section 552a; FBI policy and procedures regarding discretionary release of information in accordance with the Privacy Act; and other applicable federal orders and directives.”

We are nowhere near the bottom of this particular controversy.

8. Comey Publicly Revealed an FBI Counterintelligence Operation During Congressional Testimony

In what was an obvious play to embarrass President Trump, and while he was still FBI director, Comey told the world:

I have been authorized by the Department of Justice to confirm that the FBI, as part out our counterintelligence mission, is investigating the Russian government’s efforts to interfere in the 2016 presidential election and that includes investigating the nature of any links between individuals associated with the Trump campaign and the Russian government, and whether there was any coordination between the campaign and Russia’s efforts.

He added that this “will also include an assessment of whether any crimes were committed,” but he refused to tell the world that Trump was not under investigation. In fact, his testimony was deliberately expressed in a way to give the impression that Trump was under investigation.

But here’s the thing… Who in the Justice Department okayed the highly unusual and unethical decision to publicly announce a counterintelligence investigation? And why would Comey do such a thing, if not solely to put a cloud over the head of a sitting president?

9. Comey’s Role in Ensuring the Phony Dossier Became the “News Hook”

Although everyone, including the establishment media, knew the Steele Dossier was phony, the media still wanted to humiliate Trump by making it public. To do that, though, the dossier required an imprimatur of legitimacy… Well, what could make the dossier more newsworthy than briefing the president on it, which is what Comey was kind enough to do?

Although the dossier was total BS and Comey knew it, he still took Trump aside in private to brief him on it, even though there was no legitimate reason to do so. But then, that briefing was leaked to CNN, and the dossier was made public.

At best, what we have here is the behavior of a preening narcissist with a disturbing Hero Complex, the arson who puts out his own fires. At worst, there was an outrageous abuse of power, an abuse of the civil rights of private citizens; and as I wrote Wednesday, until there is accountability, no one can have faith in the FBI, the CIA, the Department of Justice, the FISA courts, or the overall intelligence community ever again.

The first step in this accountability will hopefully come from an upcoming inspector general report.

The final step will hopefully come from Durham, who has the power to convene grand juries, and there are reports he has already done so.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 1

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 3

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading

Top 5 Most Recently Viewed Articles

Prinses Máxima Center Enhances Genomics with Callisto™ Innovation

Updated Category News Views 194

Prinses Máxima Center's Partnership with Volta Labs The Prinses Máxima Center for Pediatric Oncology is making headlines with its recent acquisition of the Callisto™ platform from Volta Labs. This major step forward aims to enhance efficiency in sample preparation across a variety of genomics workflows, specifically designed for both Illumina and Oxford Nanopore...

Continue Reading
Boise Hunter Homes Appoints Industry Veteran Julie DeLorenzo

Updated Category News Views 474

Julie DeLorenzo Joins Boise Hunter Homes Boise Hunter Homes welcomes Julie DeLorenzo to its team as the new Director of Community Relations. This strategic move emphasizes the company’s commitment to community building and corporate stewardship. Experience and Community Commitment DeLorenzo comes with extensive experience as an Idaho Realtor, and her dedication to...

Continue Reading
Growth Prospects for Glass Prefilled Syringes in Europe

Updated Category News Views 151

Emerging Trends in the European Market for Glass Prefilled Syringes The market for glass prefilled syringes and vials in Europe is undergoing significant transformations as we witness a rapid development in healthcare and biotechnology sectors. The competitive landscape is shifting, with the adoption of innovative packaging techniques, the rise of biologics as a treatment...

Continue Reading
Man Group PLC Announces Significant Shareholdings Update

Updated Category News Views 112

Clarifying Share Interests of Man Group PLC Understanding the ownership structure in the financial world is crucial for investors. In compliance with the rules set out by the Takeover Code, disclosures regarding significant shareholdings need to be clear and transparent. Recently, Man Group PLC has taken steps to outline its relevant investments, specifically in relation...

Continue Reading
Nutrien Faces Downgrade as UBS Revises Outlook and Price Target

Updated Category News Views 87

UBS Downgrades Nutrien's Rating Amid Agricultural Concerns UBS has recently made headlines by downgrading Nutrien (NYSE: NTR) from a "buy" to a "neutral" rating. This adjustment reflects growing concerns about the agricultural market's performance and the potential impact on the company’s financial health. Weaker Agricultural Market Outlook Analysts at UBS have...

Continue Reading